Veneno De Abeja Ointment
FDA Label NDC 79974-205
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Miramar Cosmetics, Inc Dba Miramar Lab for the product Veneno De Abeja (NDC 79974-205). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding drug facts, active ingredient, purpose, uses, warnings, otc - keep out of reach of children, directions, other information, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Active Ingredient
Methyl salicylate 10.5%
Purpose
External Analgesic
Uses
• For the temporary relief of minor pains associated with muscles and joints, backache, arthritis, strains, sprains, and cramps.
Warnings
For external use only
• use only as directed
Do not use
• on wounds or damaged skin
• with a heating pad
• on children under 12 years of age
• on irritated skin
• with a bandage
• on eyes, or mucous membranes
Ask a doctor before use if redness is present on the affected area.
Stop use and ask a doctor if
• excessive irritation develops, condition worsens or symptoms persists for more than 7 days
• symptoms clear up and occur again within a few days
If pregnant or breast-feeding, ask a heath professional before use.
Otc - Keep Out Of Reach Of Children
Keep out of reach of children to avoid accidental poisoning.
If swallowed, get medical help or contact a Poison Control Center right away.
Directions
• adults and children 12 years of age or older: apply generously to affected area not more than 3 to 4 times daily.
• children under 12 years of age ask a doctor
Other Information
• Store at 15° to 25° C (59° to 77° F)
Inactive Ingredients:
Camphor, D&C yellow No.10, DMDM hydantoin, menthol, liquid paraffin, white petrolatum.
Questions?
Call 305 2618762 M-F 9AM to 4PM Eastern time.
Packaging
* Please review the disclaimer below.